Nikolai Mühlberger

Summary

Affiliation: Medical Informatics and Technology
Country: Austria

Publications

  1. pmc Therapy of uncomplicated falciparum malaria in Europe: MALTHER - a prospective observational multicentre study
    Olivier Bouchaud
    Infectious and Tropical Diseases Department, Hôpital Avicenne APHP and Université Paris 13, Bobigny, France
    Malar J 11:212. 2012
  2. pmc The low and declining risk of malaria in travellers to Latin America: is there still an indication for chemoprophylaxis?
    Ron H Behrens
    Travel Clinic, Hospital for Tropical Diseases, Mortimer Market, London, WC1E 6JB, UK
    Malar J 6:114. 2007
  3. doi Cost-effectiveness of primarily human papillomavirus-based cervical cancer screening in settings with currently established Pap screening: a systematic review commissioned by the German Federal Ministry of Health
    Nikolai Mühlberger
    University for Health Sciences, Medical Informatics and Technology, Austria
    Int J Technol Assess Health Care 24:184-92. 2008
  4. pmc HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality
    Nikolai Mühlberger
    Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, UMIT University of Health Sciences, Medical Informatics and Technology, Hall iT, Austria
    BMC Public Health 9:34. 2009
  5. doi Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection
    Gaby Sroczynski
    Department of Public Health, Information Systems and Health Technology Assessment, UMIT University of Health Sciences, Medical Informatics and Technology, Hall i T, Austria
    Eur J Public Health 19:245-53. 2009
  6. ncbi Market uptake of new antiviral drugs for the treatment of hepatitis C
    Beate Lettmeier
    Department of Public Health, Medical Decision Making and Health Technology Assessment, UMIT, University for Health Sciences, Medical Informatics and Technology, Hall iT, Austria
    J Hepatol 49:528-36. 2008
  7. pmc Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany
    Gaby Sroczynski
    UMIT University for Health Sciences, Medical Informatics and Technology, Department of Public Health, Information Systems and Health Technology Assessment, Hall i T, Austria
    GMS Health Technol Assess 6:Doc05. 2010

Collaborators

  • Uwe Siebert
  • Ruth Schwarzer
  • S Zeuzem
  • Thomas Mittendorf
  • Peter Hillemanns
  • Jutta Engel
  • Alexander Kraemer
  • Pamela Aidelsburger
  • Gaby Sroczynski
  • Olivier Bouchaud
  • Tomas Jelinek
  • Davene Wright
  • Beate Lettmeier
  • Ron H Behrens
  • Frédéric Méchaï
  • Gabriele Peyerl-Hoffmann
  • Alessandro Bartoloni
  • Philippe Parola
  • Guido Calleri
  • Alberto Matteelli
  • Anna Beltrame
  • Philippe Gautret
  • Thomas Weinke
  • Martin P Grobusch
  • Meike Probst
  • Peter Kern
  • Jan Clerinx
  • Matthias L Schmid
  • Annette Kaiser
  • Peter G Kremsner
  • Petra Schnell-Inderst
  • Karl Ulrich Petry
  • Jürgen Wasem
  • Alexander Kramer
  • Katharina Lang
  • Eva Esteban
  • Annette Conrads-Frank
  • Jiri Beran
  • Bernadette Carroll
  • Urban Hellgren
  • Fabrice Legros
  • Leo Visser
  • Bjørn Myrvang
  • Heli Siikamaki
  • Christoph Hatz

Detail Information

Publications7

  1. pmc Therapy of uncomplicated falciparum malaria in Europe: MALTHER - a prospective observational multicentre study
    Olivier Bouchaud
    Infectious and Tropical Diseases Department, Hôpital Avicenne APHP and Université Paris 13, Bobigny, France
    Malar J 11:212. 2012
    ..The objective was to summarize data on treatments to harmonize and optimize treatment for uncomplicated malaria in Europe...
  2. pmc The low and declining risk of malaria in travellers to Latin America: is there still an indication for chemoprophylaxis?
    Ron H Behrens
    Travel Clinic, Hospital for Tropical Diseases, Mortimer Market, London, WC1E 6JB, UK
    Malar J 6:114. 2007
    ..The risk of adverse events are high and the benefit of avoided benign vivax malaria is very low under current policy, which may be causing more harm than benefit...
  3. doi Cost-effectiveness of primarily human papillomavirus-based cervical cancer screening in settings with currently established Pap screening: a systematic review commissioned by the German Federal Ministry of Health
    Nikolai Mühlberger
    University for Health Sciences, Medical Informatics and Technology, Austria
    Int J Technol Assess Health Care 24:184-92. 2008
    ..Emphasis was placed on the German situation with annual Pap screening...
  4. pmc HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality
    Nikolai Mühlberger
    Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, UMIT University of Health Sciences, Medical Informatics and Technology, Hall iT, Austria
    BMC Public Health 9:34. 2009
    ..We summarised burden of disease data presently available for Europe, compared the data to current expert estimates, and identified areas in which better data are needed...
  5. doi Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection
    Gaby Sroczynski
    Department of Public Health, Information Systems and Health Technology Assessment, UMIT University of Health Sciences, Medical Informatics and Technology, Hall i T, Austria
    Eur J Public Health 19:245-53. 2009
    ..Early detection and treatment may result in better health outcomes and save costs by preventing future advanced liver disease. The evidence for long-term effectiveness and cost-effectiveness of HCV screening was systematically reviewed...
  6. ncbi Market uptake of new antiviral drugs for the treatment of hepatitis C
    Beate Lettmeier
    Department of Public Health, Medical Decision Making and Health Technology Assessment, UMIT, University for Health Sciences, Medical Informatics and Technology, Hall iT, Austria
    J Hepatol 49:528-36. 2008
    ..Peginterferon plus ribavirin is the state-of-the-art antiviral therapy for prevention of serious complications of hepatitis C. Our aim was to compare market uptake of and access to these drugs across Europe...
  7. pmc Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany
    Gaby Sroczynski
    UMIT University for Health Sciences, Medical Informatics and Technology, Department of Public Health, Information Systems and Health Technology Assessment, Hall i T, Austria
    GMS Health Technol Assess 6:Doc05. 2010
    ..HPV based primary screening for cervical cancer is currently discussed in Germany. Decisions should be based on a systematic evaluation of the long-term effectiveness and cost-effectiveness of HPV based primary screening...